APAC Biotech

    OverviewSuggest Edit

    APAC Biotech is a biotechnology company involved in research and manufacture of dendritic cell-based immunotherapy. Its solution can be used to enhance the patient’s immune response against cancer.

    Latest Updates

    Employees (est.) (Jun 2021)15
    Cybersecurity ratingAMore

    APAC Biotech Financials and Metrics

    Summary Metrics

    Founding Date


    APAC Biotech Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    APAC Biotech Online and Social Media Presence

    Embed Graph

    APAC Biotech News and Updates

    APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

    APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology.

    APAC Biotech Frequently Asked Questions

    • When was APAC Biotech founded?

      APAC Biotech was founded in 2010.

    • How many employees does APAC Biotech have?

      APAC Biotech has 15 employees.

    • Who are APAC Biotech competitors?

      Competitors of APAC Biotech include WindMIL Therapeutics, Vaccitech and Dendreon.